 Leslie Berg
Concepts (458)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein-Tyrosine Kinases | 58 | 2021 | 395 | 10.510 |
Why?
| | T-Lymphocytes | 45 | 2022 | 1736 | 4.500 |
Why?
| | CD8-Positive T-Lymphocytes | 22 | 2020 | 687 | 4.350 |
Why?
| | Receptors, Antigen, T-Cell | 39 | 2022 | 615 | 4.090 |
Why?
| | Cell Differentiation | 39 | 2017 | 1699 | 3.520 |
Why?
| | Signal Transduction | 48 | 2021 | 4509 | 3.490 |
Why?
| | Lymphocyte Activation | 31 | 2021 | 1037 | 3.150 |
Why?
| | CD4-Positive T-Lymphocytes | 25 | 2016 | 959 | 2.740 |
Why?
| | Interferon Regulatory Factors | 5 | 2020 | 29 | 2.240 |
Why?
| | Lymphocytic choriomeningitis virus | 7 | 2017 | 20 | 2.070 |
Why?
| | Thymus Gland | 23 | 2014 | 296 | 1.860 |
Why?
| | Mice | 87 | 2022 | 14859 | 1.520 |
Why?
| | Mice, Knockout | 30 | 2020 | 2565 | 1.440 |
Why?
| | Animals | 101 | 2022 | 31692 | 1.290 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 10 | 2017 | 309 | 1.280 |
Why?
| | T-Lymphocyte Subsets | 12 | 2014 | 383 | 1.260 |
Why?
| | Janus Kinase 3 | 16 | 2009 | 17 | 1.160 |
Why?
| | Intestines | 3 | 2020 | 326 | 1.150 |
Why?
| | Mice, Inbred C57BL | 39 | 2020 | 4689 | 1.110 |
Why?
| | Lymphocytic Choriomeningitis | 4 | 2015 | 12 | 1.110 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 7 | 2014 | 97 | 1.040 |
Why?
| | Th1 Cells | 4 | 2015 | 123 | 0.950 |
Why?
| | Lymphocytes | 4 | 2019 | 330 | 0.930 |
Why?
| | T-Box Domain Proteins | 6 | 2015 | 92 | 0.920 |
Why?
| | Immunologic Memory | 8 | 2017 | 313 | 0.920 |
Why?
| | Cell Proliferation | 7 | 2020 | 2186 | 0.870 |
Why?
| | Mice, Transgenic | 31 | 2015 | 1947 | 0.850 |
Why?
| | Chemotaxis, Leukocyte | 3 | 2020 | 130 | 0.820 |
Why?
| | Interleukin Receptor Common gamma Subunit | 3 | 2019 | 15 | 0.820 |
Why?
| | Cells, Cultured | 16 | 2021 | 3881 | 0.810 |
Why?
| | Flow Cytometry | 15 | 2022 | 1083 | 0.760 |
Why?
| | Arenaviridae Infections | 3 | 2017 | 7 | 0.730 |
Why?
| | Calcium | 3 | 2022 | 1104 | 0.690 |
Why?
| | CD4 Antigens | 8 | 2007 | 123 | 0.670 |
Why?
| | Transcription Factors | 11 | 2016 | 1527 | 0.640 |
Why?
| | Cytokines | 7 | 2009 | 1840 | 0.640 |
Why?
| | Killer Cells, Natural | 4 | 2014 | 380 | 0.620 |
Why?
| | Influenza A virus | 3 | 2016 | 90 | 0.600 |
Why?
| | Natural Killer T-Cells | 3 | 2014 | 63 | 0.590 |
Why?
| | Kruppel-Like Transcription Factors | 3 | 2014 | 61 | 0.590 |
Why?
| | Orthomyxoviridae Infections | 2 | 2016 | 54 | 0.580 |
Why?
| | Colitis | 2 | 2019 | 223 | 0.560 |
Why?
| | Interleukin-2 | 9 | 2019 | 413 | 0.550 |
Why?
| | Th2 Cells | 3 | 2009 | 154 | 0.540 |
Why?
| | Enhancer Elements, Genetic | 2 | 2017 | 151 | 0.530 |
Why?
| | Models, Immunological | 5 | 2012 | 92 | 0.480 |
Why?
| | Repressor Proteins | 1 | 2017 | 366 | 0.470 |
Why?
| | Amino Acid Sequence | 17 | 2015 | 1982 | 0.460 |
Why?
| | Nuclear Proteins | 4 | 2003 | 591 | 0.460 |
Why?
| | Molecular Sequence Data | 18 | 2015 | 2785 | 0.450 |
Why?
| | NFATC Transcription Factors | 6 | 2021 | 78 | 0.450 |
Why?
| | CD28 Antigens | 5 | 2013 | 47 | 0.450 |
Why?
| | Interferon-gamma | 6 | 2016 | 719 | 0.440 |
Why?
| | Gene Expression Regulation | 7 | 2021 | 2319 | 0.430 |
Why?
| | Ephrins | 2 | 2002 | 5 | 0.420 |
Why?
| | Receptor-CD3 Complex, Antigen, T-Cell | 3 | 2001 | 7 | 0.420 |
Why?
| | Membrane Proteins | 4 | 2015 | 1018 | 0.410 |
Why?
| | Histocompatibility Antigens Class I | 4 | 2010 | 172 | 0.400 |
Why?
| | Protein Kinase Inhibitors | 2 | 2015 | 785 | 0.400 |
Why?
| | Allergy and Immunology | 1 | 2012 | 51 | 0.390 |
Why?
| | Phosphorylation | 11 | 2018 | 1569 | 0.390 |
Why?
| | Epigenesis, Genetic | 2 | 2013 | 520 | 0.390 |
Why?
| | Cellular Senescence | 1 | 2013 | 152 | 0.380 |
Why?
| | Interleukin-4 | 5 | 2014 | 206 | 0.380 |
Why?
| | Thymocytes | 3 | 2014 | 28 | 0.340 |
Why?
| | Adoptive Transfer | 3 | 2020 | 195 | 0.340 |
Why?
| | Proto-Oncogene Proteins c-abl | 1 | 2008 | 7 | 0.320 |
Why?
| | X-Linked Combined Immunodeficiency Diseases | 1 | 2008 | 2 | 0.320 |
Why?
| | Major Histocompatibility Complex | 5 | 1997 | 217 | 0.320 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2009 | 127 | 0.320 |
Why?
| | Phosphoproteins | 2 | 2001 | 298 | 0.300 |
Why?
| | Phospholipase C gamma | 4 | 2018 | 26 | 0.300 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2013 | 353 | 0.300 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2010 | 226 | 0.300 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2019 | 129 | 0.300 |
Why?
| | Interleukin-15 | 4 | 2014 | 74 | 0.300 |
Why?
| | src-Family Kinases | 3 | 2018 | 88 | 0.290 |
Why?
| | Immunoglobulin E | 1 | 2009 | 314 | 0.290 |
Why?
| | Apoptosis | 5 | 2014 | 2362 | 0.290 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2008 | 88 | 0.290 |
Why?
| | Tyrosine | 4 | 2013 | 214 | 0.290 |
Why?
| | CD8 Antigens | 6 | 2007 | 69 | 0.290 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2009 | 351 | 0.280 |
Why?
| | Cell Cycle | 1 | 2009 | 542 | 0.270 |
Why?
| | Cytotoxicity, Immunologic | 3 | 2016 | 195 | 0.270 |
Why?
| | Promyelocytic Leukemia Zinc Finger Protein | 3 | 2014 | 6 | 0.270 |
Why?
| | Receptors, Eph Family | 2 | 2002 | 4 | 0.270 |
Why?
| | Mast Cells | 1 | 2007 | 116 | 0.260 |
Why?
| | Antigens, Differentiation | 3 | 2004 | 79 | 0.260 |
Why?
| | B-Lymphocytes | 4 | 2009 | 766 | 0.260 |
Why?
| | Lymphopenia | 2 | 2008 | 49 | 0.260 |
Why?
| | Cell Lineage | 6 | 2015 | 309 | 0.240 |
Why?
| | src Homology Domains | 4 | 2003 | 33 | 0.240 |
Why?
| | Up-Regulation | 6 | 2014 | 807 | 0.230 |
Why?
| | Antigens, CD1d | 2 | 2014 | 63 | 0.230 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 923 | 0.230 |
Why?
| | Gene Expression | 5 | 2014 | 1421 | 0.230 |
Why?
| | Antigens, CD | 5 | 2016 | 442 | 0.230 |
Why?
| | Humans | 33 | 2019 | 114616 | 0.220 |
Why?
| | Homeostasis | 3 | 2013 | 573 | 0.210 |
Why?
| | Receptor, EphA1 | 1 | 2002 | 1 | 0.210 |
Why?
| | MAP Kinase Signaling System | 2 | 2021 | 276 | 0.210 |
Why?
| | Receptors, Lymphocyte Homing | 2 | 2020 | 15 | 0.210 |
Why?
| | Male | 16 | 2021 | 55549 | 0.210 |
Why?
| | Interleukin-17 | 3 | 2013 | 104 | 0.210 |
Why?
| | Histocompatibility Antigens Class II | 4 | 1999 | 352 | 0.210 |
Why?
| | Cytoplasm | 2 | 2022 | 255 | 0.210 |
Why?
| | Cell Line | 7 | 2015 | 2635 | 0.200 |
Why?
| | Jurkat Cells | 6 | 2009 | 128 | 0.200 |
Why?
| | Immunophenotyping | 5 | 2016 | 274 | 0.200 |
Why?
| | Promoter Regions, Genetic | 4 | 2014 | 1131 | 0.190 |
Why?
| | NF-kappa B | 2 | 2021 | 638 | 0.190 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2004 | 800 | 0.190 |
Why?
| | CD3 Complex | 2 | 2009 | 92 | 0.190 |
Why?
| | Stem Cells | 3 | 2001 | 545 | 0.190 |
Why?
| | Polymerase Chain Reaction | 4 | 2017 | 993 | 0.190 |
Why?
| | Hematopoiesis | 4 | 2010 | 171 | 0.180 |
Why?
| | Tacrolimus | 1 | 2001 | 134 | 0.180 |
Why?
| | Hematopoietic Stem Cells | 4 | 1999 | 343 | 0.180 |
Why?
| | Ligands | 6 | 2009 | 561 | 0.180 |
Why?
| | Positive Regulatory Domain I-Binding Factor 1 | 3 | 2016 | 15 | 0.180 |
Why?
| | History, 21st Century | 2 | 2012 | 159 | 0.170 |
Why?
| | Rhadinovirus | 1 | 2020 | 16 | 0.170 |
Why?
| | Enzyme Activation | 5 | 2010 | 785 | 0.170 |
Why?
| | History, 20th Century | 2 | 2012 | 264 | 0.170 |
Why?
| | Protein Binding | 5 | 2018 | 1888 | 0.170 |
Why?
| | Immunoconjugates | 1 | 2001 | 87 | 0.170 |
Why?
| | Membrane Glycoproteins | 1 | 2002 | 430 | 0.170 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 4 | 2016 | 84 | 0.170 |
Why?
| | Spleen | 4 | 2014 | 487 | 0.170 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2000 | 367 | 0.170 |
Why?
| | Phosphatidylinositol 3-Kinases | 2 | 2001 | 329 | 0.170 |
Why?
| | Down-Regulation | 2 | 2010 | 594 | 0.160 |
Why?
| | Cricetinae | 3 | 2015 | 253 | 0.160 |
Why?
| | Receptors, Cytokine | 1 | 1999 | 33 | 0.160 |
Why?
| | Interleukin-33 | 1 | 2019 | 38 | 0.160 |
Why?
| | Blood Proteins | 1 | 2001 | 231 | 0.160 |
Why?
| | DNA-Binding Proteins | 5 | 2006 | 1313 | 0.160 |
Why?
| | Hepatocyte Nuclear Factor 1-alpha | 2 | 2015 | 16 | 0.150 |
Why?
| | Type C Phospholipases | 3 | 2003 | 65 | 0.150 |
Why?
| | DNA | 3 | 2021 | 1351 | 0.150 |
Why?
| | Virus Replication | 1 | 2020 | 395 | 0.140 |
Why?
| | Phenotype | 5 | 2006 | 2796 | 0.140 |
Why?
| | Recombinant Fusion Proteins | 6 | 2001 | 616 | 0.140 |
Why?
| | Base Sequence | 6 | 1997 | 2114 | 0.140 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2017 | 128 | 0.140 |
Why?
| | NK Cell Lectin-Like Receptor Subfamily C | 1 | 2016 | 8 | 0.140 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 1997 | 61 | 0.140 |
Why?
| | H-2 Antigens | 2 | 2014 | 110 | 0.140 |
Why?
| | Peptide Fragments | 4 | 1997 | 665 | 0.140 |
Why?
| | Lymph Nodes | 2 | 2014 | 419 | 0.140 |
Why?
| | Clonal Deletion | 4 | 2001 | 16 | 0.140 |
Why?
| | Mutation | 4 | 2013 | 3344 | 0.140 |
Why?
| | Methylation | 2 | 2014 | 207 | 0.130 |
Why?
| | Mass Spectrometry | 1 | 2019 | 633 | 0.130 |
Why?
| | Hematopoietic System | 1 | 1996 | 8 | 0.130 |
Why?
| | Microscopy, Confocal | 1 | 2017 | 304 | 0.130 |
Why?
| | Homeodomain Proteins | 2 | 2019 | 463 | 0.130 |
Why?
| | Female | 14 | 2021 | 59461 | 0.130 |
Why?
| | Introns | 1 | 1997 | 227 | 0.130 |
Why?
| | Chemokine CCL20 | 1 | 2015 | 4 | 0.130 |
Why?
| | Lymphoid Tissue | 1 | 1996 | 62 | 0.130 |
Why?
| | Chemokine CXCL11 | 1 | 2015 | 3 | 0.130 |
Why?
| | Exons | 1 | 1997 | 302 | 0.130 |
Why?
| | Receptors, Interleukin-7 | 3 | 2001 | 25 | 0.130 |
Why?
| | Germinal Center | 1 | 2015 | 48 | 0.130 |
Why?
| | Th17 Cells | 1 | 2015 | 58 | 0.120 |
Why?
| | Sea Urchins | 1 | 1995 | 7 | 0.120 |
Why?
| | Interferon Type I | 1 | 2016 | 128 | 0.120 |
Why?
| | Oligopeptides | 1 | 1996 | 236 | 0.120 |
Why?
| | Cell Survival | 3 | 2014 | 1020 | 0.120 |
Why?
| | Animal Structures | 1 | 2014 | 8 | 0.120 |
Why?
| | Cell Movement | 2 | 2013 | 868 | 0.120 |
Why?
| | beta 2-Microglobulin | 1 | 2014 | 45 | 0.120 |
Why?
| | Transfection | 4 | 2001 | 866 | 0.110 |
Why?
| | Binding Sites | 5 | 2013 | 1168 | 0.110 |
Why?
| | Spodoptera | 3 | 2010 | 36 | 0.110 |
Why?
| | Cytochrome c Group | 4 | 2002 | 36 | 0.110 |
Why?
| | Histone Deacetylase 2 | 1 | 2013 | 7 | 0.110 |
Why?
| | Protein Structure, Tertiary | 3 | 2013 | 796 | 0.110 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2013 | 27 | 0.110 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2014 | 59 | 0.110 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 66 | 0.110 |
Why?
| | Cell Migration Inhibition | 1 | 2013 | 13 | 0.110 |
Why?
| | Resting Phase, Cell Cycle | 2 | 2010 | 15 | 0.110 |
Why?
| | Mice, Mutant Strains | 2 | 2008 | 271 | 0.110 |
Why?
| | High Mobility Group Proteins | 1 | 2013 | 49 | 0.110 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2013 | 107 | 0.100 |
Why?
| | Lymphocyte Subsets | 1 | 2013 | 79 | 0.100 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2013 | 95 | 0.100 |
Why?
| | Animals, Newborn | 3 | 2006 | 778 | 0.100 |
Why?
| | Histones | 2 | 2014 | 534 | 0.100 |
Why?
| | Transcription, Genetic | 4 | 2015 | 1313 | 0.100 |
Why?
| | Arthritis, Rheumatoid | 1 | 2000 | 1002 | 0.100 |
Why?
| | Forkhead Transcription Factors | 1 | 2012 | 170 | 0.100 |
Why?
| | Acute Disease | 1 | 2014 | 910 | 0.090 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 535 | 0.090 |
Why?
| | Autoantigens | 2 | 2013 | 396 | 0.090 |
Why?
| | Biomarkers | 2 | 2018 | 3405 | 0.090 |
Why?
| | Kinetics | 4 | 2013 | 1551 | 0.090 |
Why?
| | Cell Line, Tumor | 2 | 2009 | 2710 | 0.090 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2011 | 133 | 0.090 |
Why?
| | Transplantation Chimera | 1 | 2010 | 51 | 0.090 |
Why?
| | Alleles | 2 | 1990 | 789 | 0.090 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2002 | 278 | 0.090 |
Why?
| | Mitosis | 1 | 2011 | 164 | 0.090 |
Why?
| | Interferon-beta | 1 | 2010 | 79 | 0.090 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2012 | 339 | 0.080 |
Why?
| | Rats | 2 | 2014 | 4958 | 0.080 |
Why?
| | Phosphotyrosine | 2 | 2001 | 33 | 0.080 |
Why?
| | Transcription Factors, TFII | 1 | 2009 | 37 | 0.080 |
Why?
| | Immunoglobulin Class Switching | 1 | 2009 | 15 | 0.080 |
Why?
| | Cord Blood Stem Cell Transplantation | 1 | 2010 | 91 | 0.080 |
Why?
| | T-Lymphocytes, Cytotoxic | 3 | 1996 | 154 | 0.080 |
Why?
| | Autoimmunity | 1 | 2015 | 813 | 0.080 |
Why?
| | Herpesvirus 2, Human | 1 | 2009 | 27 | 0.080 |
Why?
| | Interferon-alpha | 1 | 2010 | 186 | 0.080 |
Why?
| | Societies, Medical | 1 | 2012 | 663 | 0.080 |
Why?
| | GPI-Linked Proteins | 1 | 2009 | 54 | 0.080 |
Why?
| | Immediate-Early Proteins | 1 | 2009 | 52 | 0.080 |
Why?
| | Structure-Activity Relationship | 2 | 2001 | 501 | 0.080 |
Why?
| | Genes | 1 | 1988 | 223 | 0.080 |
Why?
| | Neoplasm Transplantation | 1 | 2008 | 228 | 0.080 |
Why?
| | Atrophy | 1 | 2008 | 152 | 0.080 |
Why?
| | STAT Transcription Factors | 1 | 2008 | 13 | 0.080 |
Why?
| | Herpes Simplex | 1 | 2009 | 87 | 0.080 |
Why?
| | STAT5 Transcription Factor | 1 | 2008 | 44 | 0.080 |
Why?
| | Tissue Donors | 1 | 2010 | 316 | 0.080 |
Why?
| | Organ Culture Techniques | 2 | 2001 | 140 | 0.080 |
Why?
| | Herpesvirus 1, Human | 1 | 2009 | 76 | 0.080 |
Why?
| | Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 3 | 1997 | 21 | 0.080 |
Why?
| | Disease Models, Animal | 1 | 2017 | 3531 | 0.080 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2009 | 139 | 0.070 |
Why?
| | Mice, Inbred C3H | 2 | 1999 | 239 | 0.070 |
Why?
| | CTLA-4 Antigen | 2 | 2013 | 76 | 0.070 |
Why?
| | Clone Cells | 2 | 2001 | 247 | 0.070 |
Why?
| | HeLa Cells | 1 | 2009 | 562 | 0.070 |
Why?
| | Multigene Family | 1 | 2008 | 190 | 0.070 |
Why?
| | Severe Combined Immunodeficiency | 2 | 1997 | 19 | 0.070 |
Why?
| | DNA, Complementary | 3 | 1996 | 256 | 0.070 |
Why?
| | Disease Susceptibility | 1 | 2008 | 316 | 0.070 |
Why?
| | Antigens, Surface | 2 | 2014 | 146 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 797 | 0.070 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2008 | 270 | 0.070 |
Why?
| | Disease Progression | 1 | 2013 | 2380 | 0.070 |
Why?
| | Transcriptome | 1 | 2012 | 724 | 0.070 |
Why?
| | Macromolecular Substances | 2 | 2001 | 200 | 0.070 |
Why?
| | Mutagenesis, Site-Directed | 2 | 1997 | 345 | 0.070 |
Why?
| | Mice, Inbred BALB C | 5 | 2016 | 1143 | 0.070 |
Why?
| | Immunity, Innate | 2 | 2013 | 720 | 0.070 |
Why?
| | Xenopus Proteins | 1 | 2006 | 55 | 0.070 |
Why?
| | Bone Marrow Cells | 3 | 2014 | 267 | 0.070 |
Why?
| | Hyaluronan Receptors | 1 | 2006 | 90 | 0.070 |
Why?
| | Lysine | 2 | 2014 | 242 | 0.070 |
Why?
| | Time Factors | 3 | 2010 | 6112 | 0.060 |
Why?
| | Conserved Sequence | 2 | 1997 | 218 | 0.060 |
Why?
| | Lectins, C-Type | 2 | 2016 | 61 | 0.060 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2005 | 60 | 0.060 |
Why?
| | Alternative Splicing | 2 | 1997 | 187 | 0.060 |
Why?
| | Genetic Variation | 1 | 1990 | 870 | 0.060 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2005 | 77 | 0.060 |
Why?
| | Protein Conformation | 3 | 2000 | 805 | 0.060 |
Why?
| | RNA, Messenger | 3 | 1997 | 2552 | 0.060 |
Why?
| | Molecular Structure | 1 | 2005 | 434 | 0.050 |
Why?
| | Point Mutation | 2 | 2010 | 216 | 0.050 |
Why?
| | Proto-Oncogene Proteins | 2 | 2005 | 608 | 0.050 |
Why?
| | Leukosialin | 2 | 2009 | 15 | 0.050 |
Why?
| | In Vitro Techniques | 1 | 2005 | 1016 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2005 | 398 | 0.050 |
Why?
| | Genes, T-Cell Receptor | 1 | 2002 | 6 | 0.050 |
Why?
| | Cysteine | 2 | 2001 | 171 | 0.050 |
Why?
| | Hybridomas | 2 | 2000 | 230 | 0.050 |
Why?
| | Fas Ligand Protein | 1 | 2002 | 57 | 0.050 |
Why?
| | ZAP-70 Protein-Tyrosine Kinase | 1 | 2001 | 8 | 0.050 |
Why?
| | Tacrolimus Binding Protein 1A | 1 | 2001 | 7 | 0.050 |
Why?
| | Fetus | 2 | 2012 | 699 | 0.050 |
Why?
| | Dimerization | 1 | 2001 | 176 | 0.050 |
Why?
| | Gene Rearrangement, T-Lymphocyte | 1 | 2001 | 13 | 0.050 |
Why?
| | Amino Acid Motifs | 1 | 2001 | 197 | 0.050 |
Why?
| | Genes, Reporter | 1 | 2001 | 257 | 0.050 |
Why?
| | Calcium Signaling | 1 | 2003 | 213 | 0.050 |
Why?
| | Abatacept | 1 | 2001 | 40 | 0.050 |
Why?
| | Cross-Linking Reagents | 1 | 2001 | 181 | 0.050 |
Why?
| | Injections, Intralymphatic | 1 | 2000 | 1 | 0.050 |
Why?
| | Mice, Congenic | 1 | 2000 | 21 | 0.050 |
Why?
| | Stromal Cells | 1 | 2001 | 96 | 0.050 |
Why?
| | Cell Division | 2 | 2000 | 758 | 0.050 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2001 | 38 | 0.050 |
Why?
| | Embryonic and Fetal Development | 1 | 2000 | 94 | 0.040 |
Why?
| | Androstadienes | 1 | 2001 | 97 | 0.040 |
Why?
| | Enzyme Inhibitors | 2 | 2001 | 750 | 0.040 |
Why?
| | Synovial Fluid | 1 | 2000 | 56 | 0.040 |
Why?
| | Granulocytes | 1 | 2000 | 77 | 0.040 |
Why?
| | Detergents | 1 | 2000 | 41 | 0.040 |
Why?
| | Interphase | 1 | 1999 | 32 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2001 | 262 | 0.040 |
Why?
| | Cell Line, Transformed | 2 | 1999 | 133 | 0.040 |
Why?
| | Leukopoiesis | 1 | 1999 | 10 | 0.040 |
Why?
| | Arginine | 1 | 2001 | 237 | 0.040 |
Why?
| | Antibodies, Blocking | 1 | 1999 | 32 | 0.040 |
Why?
| | Bone Marrow Transplantation | 1 | 2000 | 239 | 0.040 |
Why?
| | Stem Cell Factor | 1 | 1999 | 14 | 0.040 |
Why?
| | Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1998 | 8 | 0.040 |
Why?
| | Glutamic Acid | 1 | 2001 | 211 | 0.040 |
Why?
| | Chemokines, CXC | 1 | 1999 | 60 | 0.040 |
Why?
| | Interleukin-7 | 1 | 1999 | 45 | 0.040 |
Why?
| | Isoenzymes | 1 | 2000 | 283 | 0.040 |
Why?
| | Chemokine CXCL12 | 1 | 1999 | 74 | 0.040 |
Why?
| | Tumor Cells, Cultured | 2 | 1999 | 849 | 0.040 |
Why?
| | Biological Transport | 1 | 1999 | 373 | 0.040 |
Why?
| | Gene Rearrangement | 1 | 1999 | 135 | 0.040 |
Why?
| | Cricetulus | 2 | 2013 | 97 | 0.040 |
Why?
| | Ion Transport | 1 | 1998 | 55 | 0.040 |
Why?
| | Antigens, Neoplasm | 1 | 1999 | 221 | 0.040 |
Why?
| | Vanadates | 1 | 1997 | 13 | 0.040 |
Why?
| | Antibodies, Monoclonal | 3 | 1999 | 1262 | 0.040 |
Why?
| | Phosphopeptides | 1 | 1997 | 15 | 0.040 |
Why?
| | Selection, Genetic | 2 | 1989 | 242 | 0.040 |
Why?
| | Lymphocyte Count | 1 | 1997 | 133 | 0.040 |
Why?
| | Molecular Weight | 2 | 1999 | 331 | 0.040 |
Why?
| | Receptors, Interleukin-2 | 2 | 1999 | 64 | 0.040 |
Why?
| | Recombinant Proteins | 2 | 1997 | 1230 | 0.040 |
Why?
| | Receptor, EphB6 | 1 | 1996 | 1 | 0.030 |
Why?
| | Gene Deletion | 2 | 1999 | 356 | 0.030 |
Why?
| | Receptors, Interleukin | 1 | 1996 | 39 | 0.030 |
Why?
| | Agammaglobulinemia | 1 | 1996 | 30 | 0.030 |
Why?
| | Homozygote | 1 | 1997 | 187 | 0.030 |
Why?
| | Enzyme Induction | 1 | 1996 | 84 | 0.030 |
Why?
| | Mice, SCID | 2 | 2013 | 314 | 0.030 |
Why?
| | Chickens | 1 | 1996 | 177 | 0.030 |
Why?
| | Poly I-C | 1 | 2016 | 51 | 0.030 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 1996 | 69 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2000 | 695 | 0.030 |
Why?
| | Receptors, CXCR5 | 1 | 2015 | 11 | 0.030 |
Why?
| | Leukocyte Common Antigens | 1 | 1995 | 75 | 0.030 |
Why?
| | Gene Targeting | 1 | 1995 | 75 | 0.030 |
Why?
| | Cloning, Molecular | 2 | 1995 | 522 | 0.030 |
Why?
| | Organ Specificity | 1 | 1996 | 267 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 2015 | 139 | 0.030 |
Why?
| | Sequence Alignment | 1 | 1996 | 323 | 0.030 |
Why?
| | Feedback, Physiological | 1 | 2015 | 68 | 0.030 |
Why?
| | Sialoglycoproteins | 1 | 1995 | 159 | 0.030 |
Why?
| | Immunosuppressive Agents | 1 | 1999 | 646 | 0.030 |
Why?
| | Middle Aged | 2 | 2009 | 26719 | 0.030 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2015 | 17 | 0.030 |
Why?
| | Ovum | 1 | 1995 | 28 | 0.030 |
Why?
| | Consensus Sequence | 1 | 1995 | 70 | 0.030 |
Why?
| | Ribonucleases | 1 | 1995 | 52 | 0.030 |
Why?
| | Lasers | 1 | 1995 | 121 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 1997 | 399 | 0.030 |
Why?
| | Dendritic Cells | 2 | 2015 | 435 | 0.030 |
Why?
| | Zinc Fingers | 1 | 2014 | 43 | 0.030 |
Why?
| | Epitopes | 1 | 1996 | 435 | 0.030 |
Why?
| | Viral Proteins | 1 | 1996 | 281 | 0.030 |
Why?
| | Stochastic Processes | 1 | 1994 | 64 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 1995 | 246 | 0.030 |
Why?
| | Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 1994 | 21 | 0.030 |
Why?
| | CD4-CD8 Ratio | 1 | 1994 | 19 | 0.030 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 1995 | 147 | 0.030 |
Why?
| | Interferons | 1 | 2015 | 151 | 0.030 |
Why?
| | Adult | 2 | 2009 | 30528 | 0.030 |
Why?
| | DNA Primers | 1 | 1995 | 510 | 0.030 |
Why?
| | Young Adult | 1 | 2009 | 10455 | 0.030 |
Why?
| | Sf9 Cells | 1 | 2013 | 9 | 0.030 |
Why?
| | CHO Cells | 1 | 2013 | 138 | 0.030 |
Why?
| | Deuterium Exchange Measurement | 1 | 2013 | 29 | 0.030 |
Why?
| | Natural Cytotoxicity Triggering Receptor 1 | 1 | 2013 | 2 | 0.030 |
Why?
| | SOXC Transcription Factors | 1 | 2013 | 5 | 0.030 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2013 | 11 | 0.030 |
Why?
| | Biocatalysis | 1 | 2013 | 58 | 0.030 |
Why?
| | Lymphoid Enhancer-Binding Factor 1 | 1 | 2013 | 8 | 0.030 |
Why?
| | Cell Separation | 1 | 2014 | 291 | 0.030 |
Why?
| | Antigens, Ly | 1 | 2013 | 45 | 0.030 |
Why?
| | Genes, abl | 1 | 1993 | 3 | 0.030 |
Why?
| | Genes, src | 1 | 1993 | 5 | 0.030 |
Why?
| | Macrophages | 1 | 2000 | 1261 | 0.030 |
Why?
| | Evolution, Molecular | 1 | 1997 | 430 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2015 | 295 | 0.030 |
Why?
| | Models, Molecular | 2 | 2013 | 1369 | 0.030 |
Why?
| | Tissue Distribution | 1 | 1993 | 286 | 0.030 |
Why?
| | CD24 Antigen | 1 | 2012 | 20 | 0.030 |
Why?
| | Haplotypes | 1 | 1994 | 448 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2013 | 555 | 0.020 |
Why?
| | Principal Component Analysis | 1 | 2012 | 175 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 228 | 0.020 |
Why?
| | Peptides | 2 | 1996 | 848 | 0.020 |
Why?
| | Interleukins | 1 | 2013 | 236 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2013 | 337 | 0.020 |
Why?
| | Adolescent | 1 | 2009 | 17830 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1147 | 0.020 |
Why?
| | Pichinde virus | 1 | 2010 | 1 | 0.020 |
Why?
| | Autoimmune Diseases | 1 | 1994 | 382 | 0.020 |
Why?
| | H-Y Antigen | 1 | 2010 | 7 | 0.020 |
Why?
| | K562 Cells | 1 | 2010 | 73 | 0.020 |
Why?
| | Mitogens | 1 | 2010 | 58 | 0.020 |
Why?
| | Bystander Effect | 1 | 2010 | 15 | 0.020 |
Why?
| | Autoantibodies | 2 | 2015 | 1345 | 0.020 |
Why?
| | Cell Polarity | 1 | 2011 | 131 | 0.020 |
Why?
| | Baculoviridae | 1 | 2010 | 44 | 0.020 |
Why?
| | CD5 Antigens | 1 | 1989 | 8 | 0.020 |
Why?
| | NIH 3T3 Cells | 1 | 2010 | 137 | 0.020 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 1989 | 41 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 1992 | 344 | 0.020 |
Why?
| | Genes, fos | 1 | 2009 | 33 | 0.020 |
Why?
| | Proteins | 1 | 1995 | 908 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2000 | 6344 | 0.020 |
Why?
| | Pseudogenes | 1 | 1988 | 18 | 0.020 |
Why?
| | Mycobacterium tuberculosis | 1 | 2012 | 268 | 0.020 |
Why?
| | Blotting, Southern | 1 | 1988 | 68 | 0.020 |
Why?
| | Genetic Vectors | 1 | 2010 | 289 | 0.020 |
Why?
| | Species Specificity | 1 | 1990 | 542 | 0.020 |
Why?
| | Age Factors | 2 | 2012 | 2894 | 0.020 |
Why?
| | MicroRNAs | 1 | 2014 | 600 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 1988 | 396 | 0.020 |
Why?
| | Immune Tolerance | 1 | 1989 | 323 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 1990 | 610 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2010 | 1139 | 0.020 |
Why?
| | Brain | 1 | 1996 | 2371 | 0.020 |
Why?
| | Lung | 1 | 2016 | 3557 | 0.010 |
Why?
| | Aging | 1 | 1993 | 1618 | 0.010 |
Why?
| | Aged | 1 | 2000 | 19061 | 0.010 |
Why?
| | Glycosylphosphatidylinositols | 1 | 1999 | 9 | 0.010 |
Why?
| | Cell Aggregation | 1 | 1999 | 24 | 0.010 |
Why?
| | Precipitin Tests | 1 | 1999 | 88 | 0.010 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 1999 | 153 | 0.010 |
Why?
| | Lymphoma, T-Cell | 1 | 1999 | 21 | 0.010 |
Why?
| | Receptors, IgG | 1 | 1999 | 67 | 0.010 |
Why?
| | Genes, RAG-1 | 1 | 1998 | 11 | 0.010 |
Why?
| | Hydroxamic Acids | 1 | 1998 | 80 | 0.010 |
Why?
| | Cell Death | 1 | 1999 | 322 | 0.010 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 1998 | 198 | 0.010 |
Why?
| | Histone Deacetylases | 1 | 1998 | 195 | 0.010 |
Why?
| | Receptor Aggregation | 1 | 1996 | 8 | 0.010 |
Why?
| | Receptors, Interleukin-4 | 1 | 1996 | 15 | 0.010 |
Why?
| | Immunologic Techniques | 1 | 1996 | 39 | 0.010 |
Why?
| | Janus Kinase 1 | 1 | 1996 | 23 | 0.010 |
Why?
| | Proline | 1 | 1997 | 72 | 0.010 |
Why?
| | Binding, Competitive | 1 | 1996 | 193 | 0.010 |
Why?
| | Vaccines, Synthetic | 1 | 1996 | 124 | 0.010 |
Why?
| | Rosaniline Dyes | 1 | 1995 | 10 | 0.010 |
Why?
| | GRB2 Adaptor Protein | 1 | 1995 | 12 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-fyn | 1 | 1995 | 12 | 0.010 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 1995 | 41 | 0.010 |
Why?
| | Coloring Agents | 1 | 1995 | 72 | 0.010 |
Why?
| | Chromatin | 1 | 1998 | 428 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 1999 | 1629 | 0.010 |
Why?
| | Photochemistry | 1 | 1995 | 125 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1997 | 473 | 0.010 |
Why?
| | DNA Methylation | 1 | 1998 | 495 | 0.010 |
Why?
| | Immunization, Passive | 1 | 1994 | 73 | 0.010 |
Why?
| | Escherichia coli | 1 | 1997 | 720 | 0.010 |
Why?
| | Nucleocapsid Proteins | 1 | 1992 | 24 | 0.010 |
Why?
| | Viral Core Proteins | 1 | 1992 | 20 | 0.010 |
Why?
| | Nucleoproteins | 1 | 1992 | 27 | 0.010 |
Why?
| | RNA | 1 | 1998 | 809 | 0.010 |
Why?
| | ErbB Receptors | 1 | 1995 | 554 | 0.010 |
Why?
| | Immunization | 1 | 1992 | 397 | 0.010 |
Why?
| | Histocompatibility Antigens | 1 | 1989 | 98 | 0.000 |
Why?
|
|
Berg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|